Mario Gabelli Pacific Biosciences Of California, Inc. Transaction History

Gamco Investors, Inc. Et Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$10.5 - $28.5 $1.05 Million - $2.85 Million	-100,000 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$3.61 - $9.87 $960,657 - $2.63 Million	-266,110 Reduced 72.69%	100,000 $987,000
Q2 2020 Aug 13, 2020	SELL	$2.65 - $4.03 $21,200 - $32,240	-8,000 Reduced 2.14%	366,110 $1.26 Million
Q1 2020 May 14, 2020	SELL	$2.36 - $5.26 $83,341 - $185,751	-35,314 Reduced 8.63%	374,110 $1.15 Million
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $175,554 - $212,573	-38,164 Reduced 8.53%	409,424 $2.1 Million
Q3 2019 Nov 01, 2019	SELL	$4.99 - $6.16 $51,736 - $63,866	-10,368 Reduced 2.26%	447,588 $2.31 Million
Q2 2019 Aug 02, 2019	SELL	$5.92 - $7.41 $25,325 - $31,699	-4,278 Reduced 0.93%	457,956 $2.77 Million
Q1 2019 May 02, 2019	BUY	$6.8 - $7.4 $902,931 - $982,601	132,784 Added 40.3%	462,234 $3.34 Million
Q4 2018 Jan 30, 2019	BUY	$3.99 - $7.82 $1.31 Million - $2.58 Million	329,450 New	329,450 $2.44 Million

253

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $387M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.